ScPharmaceuticals Inc (SCPH) USD0.0001

Sell:$5.18Buy:$5.19$0.14 (2.77%)

NASDAQ:0.21%
Market closed | Prices delayed by at least 15 minutes
Sell:$5.18
Buy:$5.19
Change:$0.14 (2.77%)
Market closed | Prices delayed by at least 15 minutes
Sell:$5.18
Buy:$5.19
Change:$0.14 (2.77%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 August 2024
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
478,342$4.00$1,913,368.005,806,670
13 August 2024
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
21,658$4.00$86,632.00252,858
2 January 2024
John H TuckerPresident/CEO
Sell
Tax related
4,942$6.39$31,579.38140,647
2 January 2024
Rachael NokesCFO
Sell
Tax related
1,027$6.39$6,562.5320,566

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
13 August 2024
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
478,342$4.00$1,913,368.005,806,670
13 August 2024
ORBIMED ADVISORS LLCPrivate Equity
Buy
Regular purchase transaction
21,658$4.00$86,632.00252,858
2 January 2024
John H TuckerPresident/CEO
Sell
Tax related
4,942$6.39$31,579.38140,647
2 January 2024
Rachael NokesCFO
Sell
Tax related
1,027$6.39$6,562.5320,566

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.